Immundiagnostik AG
Records under this name other than the patents Immundiagnostik AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Showing 1 to 6 of 6 · Back to Immundiagnostik AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,842,851 | Relaxin for Treating Patients Afflicted of Impaired Glucose Tolerance Formerly held In force · High confidence | In force | High confidence | |
| US 10,226,512 | Method for Treating Heart Failure with Preserved Ejection Fraction by Administering Human RELAXIN-2 Formerly held In force · High confidence | In force | High confidence | |
| US 11,714,082 | Method for determination of members of the S100 family of calcium binding proteins by immunoturbidimetry Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,851,163 | Method for determining the biologically effective parathyroid hormone activity in a sample Lapsed on the fee record Ended Dec 14, 2022 · USPTO record | Lapsed on the fee record | Ended Dec 14, 2022 | USPTO record |
| US 8,133,694 | Functional vitamin D derivatives and method of determining 25-hydroxy- and 1α, 25-dihydroxy vitamin D Term ended Term ended Jul 1, 2021 · USPTO record | Term ended | Term ended Jul 1, 2021 | USPTO record |
| US 6,787,660 | Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1&agr;, dihydroxy-vitamin D Term ended Term ended Feb 20, 2021 · USPTO record | Term ended | Term ended Feb 20, 2021 | USPTO record |